DRIO Relative Valuation
DRIO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, DRIO is overvalued; if below, it's undervalued.
Historical Valuation
DarioHealth Corp (DRIO) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -2.20. The fair price of DarioHealth Corp (DRIO) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：12.48
Fair
-0.90
PE
1Y
3Y
5Y
Trailing
Forward
-4.14
EV/EBITDA
DarioHealth Corp. (DRIO) has a current EV/EBITDA of -4.14. The 5-year average EV/EBITDA is -3.03. The thresholds are as follows: Strongly Undervalued below -6.29, Undervalued between -6.29 and -4.66, Fairly Valued between -1.39 and -4.66, Overvalued between -1.39 and 0.24, and Strongly Overvalued above 0.24. The current Forward EV/EBITDA of -4.14 falls within the Historic Trend Line -Fairly Valued range.
-2.95
EV/EBIT
DarioHealth Corp. (DRIO) has a current EV/EBIT of -2.95. The 5-year average EV/EBIT is -1.75. The thresholds are as follows: Strongly Undervalued below -4.26, Undervalued between -4.26 and -3.01, Fairly Valued between -0.50 and -3.01, Overvalued between -0.50 and 0.75, and Strongly Overvalued above 0.75. The current Forward EV/EBIT of -2.95 falls within the Historic Trend Line -Fairly Valued range.
3.15
PS
DarioHealth Corp. (DRIO) has a current PS of 3.15. The 5-year average PS is 4.24. The thresholds are as follows: Strongly Undervalued below -3.40, Undervalued between -3.40 and 0.42, Fairly Valued between 8.06 and 0.42, Overvalued between 8.06 and 11.88, and Strongly Overvalued above 11.88. The current Forward PS of 3.15 falls within the Historic Trend Line -Fairly Valued range.
-3.44
P/OCF
DarioHealth Corp. (DRIO) has a current P/OCF of -3.44. The 5-year average P/OCF is -3.63. The thresholds are as follows: Strongly Undervalued below -8.63, Undervalued between -8.63 and -6.13, Fairly Valued between -1.13 and -6.13, Overvalued between -1.13 and 1.38, and Strongly Overvalued above 1.38. The current Forward P/OCF of -3.44 falls within the Historic Trend Line -Fairly Valued range.
-1.45
P/FCF
DarioHealth Corp. (DRIO) has a current P/FCF of -1.45. The 5-year average P/FCF is -3.18. The thresholds are as follows: Strongly Undervalued below -7.52, Undervalued between -7.52 and -5.35, Fairly Valued between -1.02 and -5.35, Overvalued between -1.02 and 1.15, and Strongly Overvalued above 1.15. The current Forward P/FCF of -1.45 falls within the Historic Trend Line -Fairly Valued range.
DarioHealth Corp (DRIO) has a current Price-to-Book (P/B) ratio of 1.07. Compared to its 3-year average P/B ratio of 0.79 , the current P/B ratio is approximately 34.75% higher. Relative to its 5-year average P/B ratio of 1.43, the current P/B ratio is about -25.33% higher. DarioHealth Corp (DRIO) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -86.42%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -62.49% , the current FCF yield is about -100.00% lower.
1.09
P/B
Median3y
0.79
Median5y
1.43
-33.57
FCF Yield
Median3y
-86.42
Median5y
-62.49
Competitors Valuation Multiple
The average P/S ratio for DRIO's competitors is , providing a benchmark for relative valuation. DarioHealth Corp Corp (DRIO) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of -32.55%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of DRIO decreased by 23.36% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -166.11 to -209.03.
The secondary factor is the P/E Change, contributed -16.65%to the performance.
Overall, the performance of DRIO in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
FAQ
Is DarioHealth Corp (DRIO) currently overvalued or undervalued?
What is DarioHealth Corp (DRIO) fair value?
How does DRIO's valuation metrics compare to the industry average?
What is the current P/B ratio for DarioHealth Corp (DRIO) as of Dec 05 2025?
What is the current FCF Yield for DarioHealth Corp (DRIO) as of Dec 05 2025?
What is the current Forward P/E ratio for DarioHealth Corp (DRIO) as of Dec 05 2025?